Average Analyst Estimate For This Quarter Is $2.18 Mil. Period.
$2.18 Mil which would be an increase of over 400% from prior year first quarter results. If they are anywhere close to that ... it would be unbelievable growth!!
Don't put any belief into any other numbers being talked about. Shorts just playing their stupid games again.
from a little wrag called the WALL STREET JOURNAL this week. "The most intriguing stock in my space at the moment would be TearLab Corporation (TEAR). TearLab has a first-of-its-kind point-of-care diagnostic platform in ophthalmology designed to diagnose dry-eye disease, which impacts approximately 30 million Americans. In my view, they have the "Holy Grail" in market positioning with regulatory approvals already secured, reimbursement largely in place, a massive potential market, and essentially no competition. The company is still relatively undiscovered by investors and is early in their roll-out."
You think you're smart and the market is dumb. I think you're about to get another lesson in humility here shorty. A very painful one.